Abstract
We have studied the effect of chronic treatment with imipramine, citalopram, and electroconvulsive shock (ECS) on serum and brain copper levels in rats. Chronic treatment with citalopram and imipramine (but not ECS) significantly (approx 14%) decreased the serum copper level. Chronic treatment with both drugs did not alter the brain copper level. However, chronic ECS induced a significant increase (by 36%) in the copper level in the hippocampus and also in the cerebellum (by 16%). In contrast to the zinc, where both pharmacologic and ECS treatment increased its hippocampal concentration, these two antidepressant therapy (drugs versus ECS) differ in their effect on brain copper level. These findings suggest that the mechanism by which copper is involved in ECS differs from that of any involvement in the action of the drugs studied.
Similar content being viewed by others
References
J. J. R. Frausto da Silva, and R. J. P. Williams, Copper: extracytoplasmic oxidases and matrix formation, in The Biological Chemistry of the Elements: The Inorganic Chemistry of Life, J. J. R. Frausto da Silva and R. J. P. Williams, eds., Oxford University Press, New York, pp. 388–399 (1994).
L. Stryer, Biochemistry, W. H Freeman, New York (1995).
A. Furuta, D. L. Price, C. A. Pardo, J. C. Tronsoco, Z. S. Xu, and L. J. Martin, Localization of superoxide dismutases in Alzheimer’s disease and Down’s syndrome neocortex and hippocampus, Am. J. Pathol. 146, 357–367 (1995).
S. J. Fairweather-Tait, Bioavailability of copper, Eur. J. Clin. Nutr. 51(Suppl. 1), S24-S26 (1997).
E. D. Harris, Copper transport: an overview. Proc. Soc. Exp. Biol. Med. 196, 130–140 (1991).
B. N. Patel, and S. David, A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes, J. Biol. Chem. 272, 20,185–20,190 (1997).
M. Maes, S. Sharpe, L. van Grootel, W. Wyttenbroeck, W. Cooreman, P. Cosyns, et al., Higher a1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness, J. Affect. Disord. 24, 183–192 (1992).
C. R. Hansen, M. Malecha, Jr., T. B. Mackenzie, and J. Kroll, Copper and zinc deficiences in association with depression and neurological findings, Biol. Psychiatry 18, 395–401 (1983).
M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, H. Y. Meltzer, et al., Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness, Biol. Psychiatry 42, 349–358 (1997).
M. C. Linder, Nutrition and metabolism of the trace elements, in Nutritional Biochemistry and Metabolism with Clinical Applications, M. C. Linder, ed., Elsevier Science, New York, pp. 151–198 (1985).
Q. R. Smith, Regulation of metal uptake and distribution within brain, in Nutrition and the Brain, R. J. Wurtman, and J. J. Wurtman, eds., Vol. 8, pp. 25–74 (1990).
M. Schlegel-Zawadzka, M. Krośniak, and G. Nowak, Brain copper levels after antidepressant treatment, in Metal Ions in Biology and Medicine, Ph. Collery, P. Bratter, V. Negretti de Bratter, L. Khassanova, and J. C. Etienne, eds, John Libbey Eurotext, Paris, Vol. 5, pp. 703–706 (1998).
M. A. Deibel, W. D. Ehmann, and W. R. Markesbery, Copper, iron, and zinc imbalances in severity degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress, J. Neurol. Sci. 143, 137–142 (1996).
D. A. Loeffler, P. A. LeWitt, P. L. Juneau, A. A. Sima, H. U. Nguyen, A. J. DeMaggio, et al., Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders, Brain Res. 738, 265–274 (1996).
X. L. Yang, N. Miura, Y. Kawarada, K. Terada, K. Petrukhin, T. Gilliam, et al., Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments. Biochem. J. 15(Pt. 3), 326, 897–902 (1997).
A. Crowe and E. H. Morgan, The effects of iron loading and iron deficiency on the tissue uptake of 64Cu during development in the rat, Biochim. Biophys. Acta 1291, 53–59 (1996).
C. D. Hunt and J. P. Idso, Moderate copper deprivation during gestation and lactation affects dentate gyrus and hippocampal maturation in immature male rats, J. Nutr. 125, 2700–2710 (1995).
N. Nakagawa, Studies on changes in trace elements of the brain related to aging (in Japanese), Hokkaido J. Med. Sci. 73, 181–199 (1998).
D. E. Ray, Physiological factors predisposing to neurotoxicity. Arch. Toxicol. Suppl. 19 219–226 (1997).
T. Takeda, M. Kimura, K. Yokoi, and Y. Itokawa, Effect of age and dietary protein level on tissue mineral levels in female rats, Biol. Trace Element Res. 54, 55–74 (1996).
M. Vahter, E. Lutz, B. Lind, P. Herin, T. H. Bui, and I. Krakau, Concentrations of copper, zinc and selenium in brain and kidney of second trimester fetuses and infants, J. Trace Element Med. Biol. 11, 215–222 (1997).
J. Chmielnicka and M. Nasiadek, Tissue distribution and urinary excretion of essential elements in rats orally exposed to aluminium chloride, Biol. Trace Element Res. 31, 131–138 (1991).
A. Gupta and G. S. Shukla, Ontogenic profile of brain lipids following perinatal exposure to cadmium. J. Appl. Toxicol. 16, 227–233 (1996).
J. R. Prohaska, Functions of trace elements in brain metabolism, Physiol. Rev. 67, 858–901 (1987).
P. Perez, A. Flores, A. Santamaria, C. Rios, and S. Galvan-Arzate, Changes in transition metal contents in rat brain regions after in vivo quinolinate intrastrial administration, Arch. Med. Res. 27, 449–452 (1996).
C. W. Levenson, Mechanisms of copper conservation in organs, Am. J. Clin. Nutr. 67(Suppl.), 978S-981S (1998).
C. W. Levenson and M. Janghorbani, Long-term measurement of organ copper turnover in rats by continuous feeding of a stable isotope, Anal. Biochem. 221, 243–249 (1994).
G. Nowak, and M. Schlegel-Zawadzka, Alterations in serum and brain trace elements after antidepressant treatment. Part I. Zinc, Biol. Trace Element Res. 67, 85–92 (1999).
P. Skolnick, R. T. Layer, P. Popik, G. Nowak, I. A. Paul, and R. Trullas. Adaptation of N-methyl-d-asparate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression, Pharmacopsychiatry 29, 23–26 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schlegel-Zawadzka, M., Nowak, G. Alterations in serum and brain trace element levels after antidepressant treatment. Part II. Copper. Biol Trace Elem Res 73, 37–45 (2000). https://doi.org/10.1385/BTER:73:1:37
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:73:1:37